Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic.

Aging
Zhenyu LiChun Yang

Abstract

SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) uses the angiotensin-converting enzyme 2 (ACE2) receptor for infecting and spreading in humans. Studies have shown that the widespread expression of ACE2 in human tissues may be associated with organ function damage (e.g., lung, kidney, and stomach) in patients with coronavirus disease 2019 (COVID-19). However, in neurodegenerative diseases, whose pathogenesis is closely related to advanced age, ACE2 plays a neurotrophic and protective role by activating the ACE2/Ang-(1-7)/Mas axis, thus inhibiting cognitive impairment. Early reports have revealed that the elderly are more susceptible to COVID-19 and that elderly patients with COVID-19 have faster disease progression and higher mortality. Therefore, during the COVID-19 pandemic, it is crucial to understand the role of ACE2 in neurodegenerative diseases. In this paper, we review the relationship between COVID-19, neurodegenerative diseases, and ACE2, as well as provide recommendations for the protection of elderly patients with neurodegenerative diseases during the COVID-19 pandemic.

References

Oct 17, 1998·Nature·E LeroyM H Polymeropoulos
Feb 17, 2000·Current Opinion in Neurology·R G Feldman, M H Ratner
Aug 6, 2002·Reviews in the Neurosciences·Valeria Della-MaggioreAnthony R McIntosh
Jul 4, 2006·Physiological Reviews·Martin PaulReinhold Kreutz
Jan 13, 2009·Multiple Sclerosis : Clinical and Laboratory Research·M KawajiriJ I Kira
Feb 19, 2010·Journal of Alzheimer's Disease : JAD·Chengxuan QiuLaura Fratiglioni
Mar 15, 2011·The European Journal of Neuroscience·Beate WinnerFred H Gage
Sep 28, 2012·Clinical Science·Louise M BurrellSheila K Patel
Jul 6, 2014·Alzheimer's Research & Therapy·Hadassa M JochemsenMajon Muller
Feb 11, 2015·World Journal of Nephrology·Sonoo Mizuiri, Yasushi Ohashi
Aug 30, 2016·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·UNKNOWN Alzheimer's Association
Apr 18, 2017·Current Medicinal Chemistry·L AnguianoM J Soler
Jun 8, 2018·Brain : a Journal of Neurology·John L RobinsonJohn Q Trojanowski
Jul 25, 2018·Journal of Alzheimer's Disease : JAD·Natalia P RochaAntonio L Teixeira
Apr 9, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Cornelis BlauwendraatUNKNOWN International Parkinson's Disease Genomics Consortium (IPDGC)
Feb 23, 2020·Science·Daniel WrappJason S McLellan
Feb 29, 2020·JAMA : the Journal of the American Medical Association·Carlos Del Rio, Preeti N Malani
Mar 11, 2020·Journal of the American Geriatrics Society·William B Applegate, Joseph G Ouslander
Mar 13, 2020·Journal of the American Geriatrics Society·Antoine Garnier-CrussardPierre Krolak-Salmon
Mar 19, 2020·International Journal of Molecular Sciences·Christopher D MorroneJoAnne McLaurin
Mar 20, 2020·JAMA : the Journal of the American Medical Association·Matt ArentzMelissa Lee
Mar 20, 2020·Acta Bio-medica : Atenei Parmensis·Domenico Cucinotta, Maurizio Vanelli
Mar 28, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas C HanffAmir M Mohareb
Apr 8, 2020·Journal of the American Geriatrics Society·Zainab ShahidRohit Jain
Apr 10, 2020·The European Respiratory Journal·Janice M LeungDon D Sin
Apr 13, 2020·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·TieLong ChenYong Xiong
Apr 19, 2020·BMJ : British Medical Journal·John Ashcroft
Apr 19, 2020·Gut·Markus F Neurath
Apr 20, 2020·The Lancet Infectious Diseases·Judith R Glynn

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
electron microscopy

Related Concepts

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.